生物科技
Major bio firm Alteogen seeks KOSPI listing
由 AI 报道 AI 生成的图像
Alteogen, the top market cap company on South Korea's secondary KOSDAQ market, has decided to move to the main KOSPI bourse to secure stable funding and enhance its corporate value. Shareholders approved the proposal on Monday, with the firm aiming for a listing next year.
随着美中紧张关系加剧，美国制药公司回岸生产和中国供应链重组，中国合同制药企业如药明康德、药明生物和药明XDC面临长期收入前景不明朗。杰富瑞亚洲医疗研究主管崔翠表示，2026和2027年收益有保障，但长期订单增长缺乏清晰度。
由 AI 报道
Gestala, a new entrant in China's expanding brain-computer interface sector, aims to connect with the brain using ultrasound technology without needing implants. This approach highlights the industry's shift toward less invasive methods. The company emerges amid rapid growth in Chinese biotech innovation.
Vaccine therapy for malignant glioma is advancing, with calls for expedited approvals to treat this aggressive brain cancer. The approach has potential to save lives and is part of efforts for rare disease treatments. Early results indicate effectiveness without traditional chemo or radiation.
由 AI 报道 事实核查
A new treatment tested in brain organoids with glioblastoma outperformed chemotherapy and dramatically reduced tumors in mice. Human trials are upcoming. The approach also explores stem cell stimulation and aging cell rejuvenation for broader immunotherapy applications.